Journal: Journal of Family Medicine and Primary Care
Article Title: Evaluation of the diagnosis and treatment options for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
doi: 10.4103/jfmpc.jfmpc_1735_21
Figure Lengend Snippet: Some treatments of COVID-19
Article Snippet: Mortality was 6.7% in the treatment group and 11.9% in the control group on day 15 and 11.4% in the treatment node compared to 15.2% in the control group by day 29. The most common unpleasant side effects in at least 5% of all patients: reduction glomerular filtration rate, decrease in hemoglobin level, decrease in lymphocyte count, respiratory failure, anemia, pyrexia, hyperglycemia, increase in blood creatinine level, and increase in blood glucose level , 1062 patients (541 in the treatment group, 521 in the control group), mean age 15 ± 58.9 , Remdesivir with basic treatment , [ ] .
Techniques: Filtration